Citalopram Hydrobromide Working Standard (Secondary Reference Standard)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

59729-32-7Citalopram Hydrobromide Working Standard (Secondary Reference Standard)

● Under Development

Catalogue No.:VE0027141
CAS No.:59729-32-7
Mol. Formula:C20H22BrFN2O
Mol. Weight:405.3 g/mol

Additional information on CAS 59729-32-7

Parent drug

Citalopram Hydrobromide / Citalopram

IUPAC Name

1-[3-(Dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

N#CC1=CC=C2C(C3=CC=C(F)C=C3)(CCCN(C)C)OCC2=C1.Br

InChI

InChI=1S/C20H21FN2O.BrH/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;/h4-9,12H,3,10-11,14H2,1-2H3;1H

Description

Citalopram Hydrobromide Working Standard (Secondary Reference Standard), CAS 59729-32-7, is supplied as a characterized material to support analytical method development and research. Each lot is supported by a certificate of analysis reporting identity, assay, and impurity profile to facilitate method validation, system suitability testing, and instrument calibration. The material is traceable to internal controls and intended for controlled laboratory use by trained analysts. It is intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url